NCT05746039: Feasibility of Semaglutide in Advanced Lung Disease

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Sarcoidosis, Pulmonary, Pulmonary Hypertension